However, no significant difference regarding BM plasma IL-17 level was found between ND AML patients (median, 0.77pg/ml; range, 0.52–1.02pg/ml) and CR (median, 0.83pg/ml; range, 0.30–1.36pg/ml) or between ND AML patients and controls (median, 0.92pg/ml; range, 0.30–1.36pg/ml) (Fig 2D). The gene discussed is IL17A; the disease is acute myeloid leukemia.